Safe & secure AB4AD (Antibodies for Alzheimer's Disease) wallet
Take control of your AB4AD (Antibodies for Alzheimer's Disease) assets with complete confidence in the Trezor ecosystem.
- Secured by your hardware wallet
- Use with compatible hot wallets
- Trusted by over 2 million customers

Send & receive your AB4AD (Antibodies for Alzheimer's Disease) with the Trezor Suite app
Send & receive
Trezor hardware wallets that support AB4AD (Antibodies for Alzheimer's Disease)
Sync your Trezor with wallet apps
Manage your AB4AD (Antibodies for Alzheimer's Disease) with your Trezor hardware wallet synced with several wallet apps.
Trezor Suite
MetaMask
Rabby
Supported AB4AD (Antibodies for Alzheimer's Disease) Network
- Base
Why a hardware wallet?
Go offline with Trezor
- You own 100% of your coins
- Your wallet is 100% safe offline
- Your data is 100% anonymous
- Your coins aren’t tied to any company
Online exchanges
- If an exchange fails, you lose your coins
- Exchanges are targets for hackers
- Your personal data may be exposed
- You don’t truly own your coins
How to AB4AD on Trezor
Connect your Trezor
Open a third-party wallet app
Manage your assets
Make the most of your AB4AD
Trezor keeps your AB4AD secure
Protected by Secure ElementThe best defense against both online and offline threats
Your tokens, your controlAbsolute control of every transaction with on-device confirmation
Security starts with open-sourceTransparent wallet design makes your Trezor better and safer
Clear & simple wallet backupRecover access to your digital assets with a new backup standard
Confidence from day onePackaging & device security seals protect your Trezor’s integrity
Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).

